UPDATE: Alexion Completes Rolling BLA Submission to U.S. FDA for Asfotase Alfa
December 30, 2014 at 06:35 AM EST
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced today completion of the rolling submission of a Biologics License Application ...